Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1486 AL 1500

[Dementia in the elderly: Complexity, ageing and frailty. Geriatric syndrome]

Marin-Carmona JM, Formiga F.

Rev Esp Geriatr Gerontol. 2020 Mar-Apr;55(2):63-64. doi: 10.1016/j.regg.2019.11.001. Epub 2019 Dec 26.

CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia

Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P, Baiardi S, Zenesini C, Huss A, Cortelli P, Capellari S, Otto M, Parchi P.

Alzheimers Res Ther. 2019 Dec 31;12(1):2. doi: 10.1186/s13195-019-0562-4.

Applications of biosensors in Alzheimer's disease diagnosis

Brazaca LC, Sampaio I, Zucolotto V, Janegitz BC.

Talanta. 2020 Apr 1;210:120644. doi: 10.1016/j.talanta.2019.120644. Epub 2019 Dec 12.

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome

Botté A, Potier MC.

Prog Brain Res. 2020;251:209-243. doi: 10.1016/bs.pbr.2019.10.002. Epub 2019 Nov 20.

Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy

Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E, Mirzaei H.

J Cell Physiol. 2019 Mar;234(3):2296-2305. doi: 10.1002/jcp.27214. Epub 2018 Sep 7.

CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review

Zhao L.

Gerontology. 2019;65(4):323-331. doi: 10.1159/000492596. Epub 2018 Dec 12.

Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond

Grasso G.

Mass Spectrom Rev. 2019 Jan;38(1):34-48. doi: 10.1002/mas.21566. Epub 2018 Jun 15.

A Network-Based Perspective in Alzheimer's Disease: Current State and an Integrative Framework

Dragomir A, Vrahatis AG, Bezerianos A.

IEEE J Biomed Health Inform. 2019 Jan;23(1):14-25. doi: 10.1109/JBHI.2018.2863202. Epub 2018 Aug 3.

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type

Danjou P, Viardot G, Maurice D, Garcés P, Wams EJ, Phillips KG, Bertaina-Anglade V, McCarthy AP, Pemberton DJ.

Neurosci Biobehav Rev. 2019 Feb;97:70-84. doi: 10.1016/j.neubiorev.2018.09.004. Epub 2018 Sep 6.

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13.

Blood-based biomarkers for Alzheimer's disease-An update

Zetterberg H.

J Neurosci Methods. 2019 May 1;319:2-6. doi: 10.1016/j.jneumeth.2018.10.025. Epub 2018 Oct 25.

microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer

Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U.

Ageing Res Rev. 2019 Jan;49:125-143. doi: 10.1016/j.arr.2018.10.008. Epub 2018 Nov 2.

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

Cohen AD, Landau SM, Snitz BE, Klunk WE, Blennow K, Zetterberg H.

Mol Cell Neurosci. 2019 Jun;97:3-17. doi: 10.1016/j.mcn.2018.12.004. Epub 2018 Dec 8.

Diet and biomarkers of Alzheimer's disease: a systematic review and meta-analysis

Hill E, Goodwill AM, Gorelik A, Szoeke C.

Neurobiol Aging. 2019 Apr;76:45-52. doi: 10.1016/j.neurobiolaging.2018.12.008. Epub 2018 Dec 27.

Value of testosterone in saliva in the diagnosis of Alzheimer's disease

de la Rubia Ortí JE, García-Pardo MP, Rochina MJ.

Med Clin (Barc). 2019 Jan 18;152(2):75-76. doi: 10.1016/j.medcli.2018.03.006. Epub 2018 Apr 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias